tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ATNM Stock Latest News

Actinium Pharmaceuticals announces preclinical data for ATNM-400
The FlyActinium Pharmaceuticals announces preclinical data for ATNM-400
4h ago
ATNM
Actinium Pharmaceuticals Holds Annual Stockholders Meeting
PremiumCompany Announcements
Actinium Pharmaceuticals Holds Annual Stockholders Meeting
5d ago
8K
ATNM
Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies and Strong Financial Position Support Buy Rating
PremiumRatings
Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies and Strong Financial Position Support Buy Rating
12d ago
ATNM
Actinium Pharmaceuticals: Promising Developments and Strong Financial Health Support Buy Rating
PremiumRatings
Actinium Pharmaceuticals: Promising Developments and Strong Financial Health Support Buy Rating
14d ago
ATNM
Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies Drive Buy Rating
PremiumRatings
Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies Drive Buy Rating
26d ago
ATNM
Actinium Pharmaceuticals: Promising Preclinical Success and Innovative Radiotherapy Developments Drive Buy Rating
PremiumRatingsActinium Pharmaceuticals: Promising Preclinical Success and Innovative Radiotherapy Developments Drive Buy Rating
1M ago
ATNM
Actinium Pharmaceuticals’ ATNM-400 shows superior anti-tumor activity
Premium
The Fly
Actinium Pharmaceuticals’ ATNM-400 shows superior anti-tumor activity
1M ago
AZN
JNJ
Actinium Pharmaceuticals’ ATNM-400: A Promising Radiotherapeutic Advancing Oncology Treatment Options
Premium
Ratings
Actinium Pharmaceuticals’ ATNM-400: A Promising Radiotherapeutic Advancing Oncology Treatment Options
1M ago
ATNM
Actinium presents preclinical data for ATNM-400
PremiumThe Fly
Actinium presents preclinical data for ATNM-400
1M ago
ATNM
Promising Pipeline and Strategic Developments Drive Buy Rating for Actinium Pharmaceuticals
PremiumRatings
Promising Pipeline and Strategic Developments Drive Buy Rating for Actinium Pharmaceuticals
2M ago
ATNM
Actinium Pharmaceuticals to announces preclinical data from ATNM-400 program
PremiumThe Fly
Actinium Pharmaceuticals to announces preclinical data from ATNM-400 program
2M ago
ATNM
Actinium Pharmaceuticals’ New AML Treatment Study: A Potential Game Changer
PremiumCompany Announcements
Actinium Pharmaceuticals’ New AML Treatment Study: A Potential Game Changer
3M ago
ATNM
Actinium Pharmaceuticals: Promising Advancements in Radiopharmaceutical Pipeline Drive Buy Rating
PremiumRatingsActinium Pharmaceuticals: Promising Advancements in Radiopharmaceutical Pipeline Drive Buy Rating
4M ago
ATNM
Actinium Pharmaceuticals: Promising Pipeline and Strong Financials Drive Buy Rating
Premium
Ratings
Actinium Pharmaceuticals: Promising Pipeline and Strong Financials Drive Buy Rating
4M ago
ATNM
Actinium Pharmaceuticals’ ATNM-400 Shows Promise in Prostate Cancer Treatment, Earning Buy Rating
Premium
Ratings
Actinium Pharmaceuticals’ ATNM-400 Shows Promise in Prostate Cancer Treatment, Earning Buy Rating
4M ago
ATNM
Actinium Pharmaceuticals’ ATNM-400 shows improved survival in prostate cancer
PremiumThe Fly
Actinium Pharmaceuticals’ ATNM-400 shows improved survival in prostate cancer
4M ago
ATNM
Promising Preclinical Results for ATNM-400 Drive Buy Rating for Actinium Pharmaceuticals
PremiumRatings
Promising Preclinical Results for ATNM-400 Drive Buy Rating for Actinium Pharmaceuticals
5M ago
ATNM
Positive Outlook on Actinium Pharmaceuticals: Promising Preclinical Data and Strong Financial Position Drive Buy Rating
PremiumRatings
Positive Outlook on Actinium Pharmaceuticals: Promising Preclinical Data and Strong Financial Position Drive Buy Rating
5M ago
ATNM
Actinium highlights expanded data set for ATNM-400 in prostate cancer
PremiumThe Fly
Actinium highlights expanded data set for ATNM-400 in prostate cancer
5M ago
ATNM
ATNM Lawsuit Alert! Class Action Lawsuit Against Actinium Pharmaceuticals
PremiumMarket NewsATNM Lawsuit Alert! Class Action Lawsuit Against Actinium Pharmaceuticals
7M ago
ATNM
Promising Advancements and Strategic Collaborations Justify Buy Rating for Actinium Pharmaceuticals
Premium
Ratings
Promising Advancements and Strategic Collaborations Justify Buy Rating for Actinium Pharmaceuticals
7M ago
ATNM
Actinium Pharmaceuticals: Promising Pipeline and Strategic Partnerships Drive Buy Rating
Premium
Ratings
Actinium Pharmaceuticals: Promising Pipeline and Strategic Partnerships Drive Buy Rating
7M ago
ATNM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >